JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 37:1461-1466
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khaper, N.
Right arrow Articles by Singal, P. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khaper, N.
Right arrow Articles by Singal, P. K.

Modulation of oxidative stress by a selective inhibition of angiotensin II type 1 receptors in MI rats

Neelam Khaper, MSca and Pawan K. Singal, PhD, DSc, FACCa

a Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada



View larger version (37K):

[in a new window]
 
Figure 1 Myocardial antioxidant enzyme activities in the 16-week control (CONT) and myocardial infarction (MI) rats with and without losartan treatment. Data are mean ± standard error of the mean, from 5 to 7 animals, with each assay done in duplicate. (A) catalase; (B) glutathione peroxidase; (C) superoxide dismutase. *Significantly different from the respective control group; @Significantly different (p < 0.05) from the respective untreated control and MI groups.

 


View larger version (41K):

[in a new window]
 
Figure 2 Redox ratio (A) and lipid hydroperoxide content (B) in the 16-week control and MI rats with and without losartan treatment. Data are mean ± SEM from 8 to 10 animals with each assay done in duplicate. *Significantly different (p < 0.05) from the respective control group; @Significantly different from the respective untreated control or myocardial infarction group.

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.